Related Experiment Video
Updated: May 11, 2026
08:43
Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase G6PI-Induced RA Mice
Published on: January 31, 2020
6.8K
Recombinant Human Proteoglycan Aggrecan-G1 Domain-induced Arthritis (GIA) Mouse Model.
Katalin Olasz1, Ferenc Boldizsar1
1Department of Immunology and Biotechnology, University of Pécs, Medical School, Pécs, Hungary.
Current Protocols
|May 16, 2024
Summary
This study details the recombinant human proteoglycan aggrecan-G1 domain (rhG1)-induced arthritis (GIA) mouse model, a valuable tool for rheumatoid arthritis (RA) research. The GIA model mimics RA
Area of Science:
- Immunology
- Rheumatology
- Biochemistry
Background:
- Rheumatoid arthritis (RA) is a complex autoimmune disease characterized by joint inflammation and destruction.
- The development of accurate animal models is crucial for understanding RA pathogenesis and testing therapeutic interventions.
- The aggrecan G-1 domain is a key autoantigen implicated in RA.
Purpose of the Study:
- To provide a comprehensive protocol for the induction and characterization of the recombinant human proteoglycan aggrecan-G1 domain (rhG1)-induced arthritis (GIA) mouse model.
- To detail methods for antigen production, immunization, and assessment of clinical and laboratory parameters in the GIA model.
- To facilitate the use of the GIA model for studying various aspects of autoimmune arthritis.
Main Methods:
- Production and purification of the rhG1 antigen using a mammalian expression system and affinity chromatography.
- Immunization of BALB/c mice with rhG1 emulsified in dimethyldioctadecylammonium (DDA) adjuvant.
- Stepwise monitoring of arthritis development, including clinical assessment, autoantibody production, cytokine measurement, cell proliferation assays, histological analysis, and micro-computed tomography.
Main Results:
- The GIA model recapitulates the stepwise progression of RA, including preclinical, early, and late stages.
- Detectable T and B cell activation occurs during the preclinical stage, followed by autoantibody production and overt inflammation in later stages.
- The model allows for the evaluation of inflammation, cartilage and bone destruction, and ankylosis.
Conclusions:
- The rhG1-induced arthritis (GIA) mouse model is a robust and reproducible model for studying rheumatoid arthritis.
- The detailed protocols provided enable researchers to effectively utilize the GIA model for investigating autoimmune arthritis.
- This model serves as a valuable platform for exploring RA pathogenesis and evaluating potential therapeutic strategies.
